173 related articles for article (PubMed ID: 31668267)
1. Serologic Diagnosis of Rheumatoid Arthritis.
Allard-Chamard H; Boire G
Clin Lab Med; 2019 Dec; 39(4):525-537. PubMed ID: 31668267
[TBL] [Abstract][Full Text] [Related]
2. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
3. Combination of ultrasound power Doppler-verified synovitis and seropositivity accurately identifies patients with early-stage rheumatoid arthritis.
Kawashiri SY; Fujikawa K; Nishino A; Takatani A; Shimizu T; Umeda M; Fukui S; Igawa T; Koga T; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Mizokami A; Maeda T; Kawakami A
Int J Rheum Dis; 2019 May; 22(5):842-851. PubMed ID: 30883001
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis.
de Brito Rocha S; Baldo DC; Andrade LEC
Adv Rheumatol; 2019 Jan; 59(1):2. PubMed ID: 30657101
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.
Zengin O; Yıldız H; Demir ZH; Dağ MS; Aydınlı M; Onat AM; Kısacık B
Adv Clin Exp Med; 2017 Sep; 26(6):987-990. PubMed ID: 29068601
[TBL] [Abstract][Full Text] [Related]
6. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
Front Immunol; 2018; 9():876. PubMed ID: 29740454
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
[TBL] [Abstract][Full Text] [Related]
8. Seropositivity of Rheumatoid Arthritis Specific Tests in a Patient With Nephrotic Syndrome: Successful Treatment With Rituximab.
Mirzaei A; Ataeipoor Y; Asgari M; Zabihiyeganeh M
Iran J Kidney Dis; 2017 Nov; 11(6):467-468. PubMed ID: 29190608
[TBL] [Abstract][Full Text] [Related]
9. Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR/EULAR 2010 classification criteria for rheumatoid arthritis.
Tenstad HB; Nilsson AC; Dellgren CD; Lindegaard HM; Rubin KH; Lillevang ST
Scand J Rheumatol; 2020 Jan; 49(1):18-20. PubMed ID: 31264518
[No Abstract] [Full Text] [Related]
10. High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study.
Takeuchi T; Miyasaka N; Inui T; Yano T; Yoshinari T; Abe T; Koike T
Arthritis Res Ther; 2017 Sep; 19(1):194. PubMed ID: 28865493
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
[TBL] [Abstract][Full Text] [Related]
12. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis.
Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH
Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3η protein: a promising biomarker for rheumatoid arthritis.
Zeng T; Tan L
Biomark Med; 2018 Aug; 12(8):917-925. PubMed ID: 30022679
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.
Elshafie AI; Elbagir S; Aledrissy MIE; Elagib EM; Nur MAM; Rönnelid J
Clin Rheumatol; 2019 Jun; 38(6):1545-1553. PubMed ID: 30656490
[TBL] [Abstract][Full Text] [Related]
15. Insights of rheumatoid arthritis biomarkers.
Kolarz B; Podgorska D; Podgorski R
Biomarkers; 2021 May; 26(3):185-195. PubMed ID: 32662676
[TBL] [Abstract][Full Text] [Related]
16. Analysis of four serum biomarkers in rheumatoid arthritis: association with extra articular manifestations in patients and arthralgia in relatives.
Nass FR; Skare TL; Goeldner I; Nisihara R; Messias-Reason IT; Utiyama SRR
Rev Bras Reumatol Engl Ed; 2017; 57(4):286-293. PubMed ID: 28743354
[TBL] [Abstract][Full Text] [Related]
17. Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
Vos I; Van Mol C; Trouw LA; Mahler M; Bakker JA; Van Offel J; De Clerck L; Huizinga TW
Clin Rheumatol; 2017 Jul; 36(7):1487-1492. PubMed ID: 28578492
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
Chang PY; Yang CT; Cheng CH; Yu KH
Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
[TBL] [Abstract][Full Text] [Related]
19. An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients.
Martínez-Estupiñán L; Hernández-Flórez D; Janta I; Ovalles-Bonilla JG; Nieto JC; González-Fernández CM; Del Río T; Monteagudo I; López-Longo FJ; Naredo E; Valor L
Clin Exp Rheumatol; 2018; 36(1):88-93. PubMed ID: 28850020
[TBL] [Abstract][Full Text] [Related]
20. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.
Farid SSh; Azizi G; Mirshafiey A
Int J Rheum Dis; 2013 Aug; 16(4):379-86. PubMed ID: 23992255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
